Patients with non-Jo-1 anti-RNA-synthetase autoantibodies have worse survival than Jo-1 positive patients

Annals of the Rheumatic Diseases

Volumn 72, Issue 7, 2013, Pages

  Hervier, Baptiste ^a   Devilliers, Hervé ^b   Benveniste, Olivier ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b DIJON UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARGYL RNA SYNTHETASE AUTOANTIBODY; AUTOANTIBODY; GLYCYL RNA SYNTHETASE AUTOANTIBODY; ISOLEUCYL RNA SYNTHETASE AUTOANTIBODY; JO 1 ANTIBODY; RNA SYNTHETASE AUTOANTIBODY; UNCLASSIFIED DRUG;

AGE; ANTIBODY SPECIFICITY; ANTISYNTHETASE SYNDROME; COHORT ANALYSIS; DELAYED DIAGNOSIS; DISEASE ASSOCIATION; ETHNICITY; GENDER; LETTER; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE;

ADULT ONSET STILL'S DISEASE; AMYLOIDOSIS; ANALGESICS;

AMINO ACYL-TRNA SYNTHETASES; ANTIBODIES, ANTINUCLEAR; ASPARTATE-TRNA LIGASE; AUTOANTIBODIES; GLYCINE-TRNA LIGASE; HISTIDINE-TRNA LIGASE; HUMANS; ISOLEUCINE-TRNA LIGASE; MYOSITIS; RNA, TRANSFER, AMINO ACYL;

EID: 84878413299     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2013-203605     Document Type: Letter

References (4)

1. Aggarwal R, Cassidy E, Fertig N, et al. Patients with non-Jo-1 anti-tRNA-synthetase autoantibodies have worse survival than Jo-1 positive patients. Ann Rheum Dis 2013. Published Online First 26 Feb 2013.
2. Hervier B, Devilliers H, Stanciu R, et al. Hierarchical cluster and survival analyses of antisynthetase syndrome: phenotype and outcome are correlated with anti-tRNA synthetase antibody specificity. Autoimmun Rev 2012;12 :210-17.
3. Marie I, Josse S, Decaux O, et al. Comparison of long-term outcome between anti-Jo1- and anti-PL7/PL12 positive patients with antisynthetase syndrome. Autoimmun Rev 2012;11:739-45.
4. Hervier B, Meyer A, Dieval C, et al. Pulmonary hypertension in antisynthetase syndrome: prevalence, etiology and survival. Eur Respir J 2013. [Epub ahead of print 8 Feb 2013].